Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.
Press releases published on August 28, 2025
SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel
GlobeNewswire
·
August 28, 2025
TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
GlobeNewswire
·
August 28, 2025
FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLA Outlook Therapeutics plans to work with FDA to address the Agency’s issues Company to host a conference call and webcast today, August 28th at 8:30 AM ET ISELIN, N.J., Aug. 28, 2025 ( …
KFSHRC Advances Nursing Excellence Through Specialized Training
GlobeNewswire
·
August 28, 2025
RIYADH, Saudi Arabia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …
Sai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL
GlobeNewswire
·
August 28, 2025
HYDERABAD, India, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new …
ProNephro AKI™ (NGAL), til tidlig diagnosticering af akut nyreskade, er nu kommercielt tilgængelig på laboratorier i USA gennem BioPortos samarbejde med Roche Diagnostics.
GlobeNewswire
·
August 28, 2025
28. august 2025 Meddelelse ProNephro AKI™ (NGAL), til tidlig diagnosticering af akut nyreskade, er nu kommercielt tilgængelig på laboratorier i USA gennem BioPortos samarbejde med Roche Diagnostics. Samarbejdet med Roche Diagnostics markerer det første væ …
ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics.
GlobeNewswire
·
August 28, 2025
August 28, 2025 News Release ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics. Collaboration with Roche Diagnostics is first major commercial …
TOLREMO therapeutics Receives Two FDA Fast Track Designations for TT125-802 in Pretreated, Advanced or Metastatic NSCLC With Either an EGFR or a KRAS-G12C Mutation
GlobeNewswire
·
August 28, 2025
TT125-802 is a small molecule CBP/p300 bromodomain inhibitor that shows clinical activity as single agent in solid tumors, including advanced EGFR-mutated and KRAS-G12C-mutated non-small cell lung cancer (NSCLC) 1 in 5 cancer-related deaths in the US are …
Oculis to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 28, 2025
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant unmet …
Dermatology Expert Laurel Leithauser, MD, FFAD, FACMS, Offers UV Protection and Skin Cancer Screening Advice in HelloNation
GlobeNewswire
·
August 28, 2025
TRAVERSE CITY, Mich., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Why should residents in Traverse City treat a skin cancer screening like any other annual health exam? In HelloNation, Dr. Laurel Leithauser of Leithauser Skin Institute explains why routine checkups …
Veterinary Expert Dr. Ben Nemmers Explains What Most People Don’t Realize About Boarding with Vet Care in HelloNation
GlobeNewswire
·
August 28, 2025
CEDAR FALLS, Iowa, Aug. 28, 2025 (GLOBE NEWSWIRE) -- What makes pet boarding with veterinary care different from a standard kennel stay? In HelloNation, Dr. Ben Nemmers of Companion Animal Clinic …
argenx to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
August 28, 2025 Amsterdam, the Netherlands – argenx (Euronext …
Idorsia’s TRYVIO – First FDA-approved therapy to target the endothelin pathway for systemic hypertension
GlobeNewswire
·
August 28, 2025
Allschwil, Switzerland – August 28, 2025 Idorsia Ltd (SIX: IDIA) releases an OnDemand investor webcast outlining how TRYVIO™ (aprocitentan) – the first and only hypertension therapy targeting the endothelin pathway – fits into the treatment landscape for …
Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock
GlobeNewswire
·
August 28, 2025
- The offering was made to two new fundamental institutional investors - - The Company intends to use the net proceeds to fund preparation for our Phase 3 programs of zervimesine in neurodegenerative disorders - PURCHASE, N.Y., Aug. 27, 2025 (GLOBE …